Testing effectiveness (Phase 2)UnknownNCT06231680
What this trial is testing
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Who this might be right for
Lung Cancer, Nonsmall CellEsophageal Carcinoma
Henan Cancer Hospital 132